Your browser doesn't support javascript.
Factor VIII, Fibrinogen and Heparin Resistance in COVID-19 Patients with Thromboembolism: How Should We Manage the Anticoagulation Therapy?
Savioli, Felicio; Claro, Maurício; da Silva Ramos, Fernando Jose; Pastore, Laerte.
  • Savioli F; Critical Care Medicine Department, Hospital Sírio Libanês, Sao Paulo, Brazil.
  • Claro M; Critical Care Medicine Department, Hospital Sírio Libanês, Sao Paulo, Brazil.
  • da Silva Ramos FJ; Critical Care Medicine Department, Hospital Sírio Libanês, Sao Paulo, Brazil.
  • Pastore L; Critical Care Medicine Department, Hospital Sírio Libanês, Sao Paulo, Brazil.
Clin Appl Thromb Hemost ; 28: 10760296221087692, 2022.
Article in English | MEDLINE | ID: covidwho-1753042

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thromboembolism / COVID-19 Drug Treatment Limits: Humans Language: English Journal: Clin Appl Thromb Hemost Journal subject: Vascular Diseases Year: 2022 Document Type: Article Affiliation country: 10760296221087692

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Thromboembolism / COVID-19 Drug Treatment Limits: Humans Language: English Journal: Clin Appl Thromb Hemost Journal subject: Vascular Diseases Year: 2022 Document Type: Article Affiliation country: 10760296221087692